EMI (Encore Medical) FCF Margin %: -19.38% (As of Dec. 2025)


What is Encore Medical FCF Margin %?

Encore Medical EMI FCF Margin % is -19.38% as of Dec. 2025.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Encore Medical's Free Cash Flow for the three months ended in Dec. 2025 was $-0.25 Mil. Encore Medical's Revenue for the three months ended in Dec. 2025 was $1.30 Mil. Therefore, Encore Medical's FCF Margin % for the quarter that ended in Dec. 2025 was -19.38%.

As of today, Encore Medical's current FCF Yield % is 0.00%.

The historical rank and industry rank for Encore Medical's FCF Margin % or its related term are showing as below:


EMI's FCF Margin % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: -0.1
* Ranked among companies with meaningful FCF Margin % only.

Encore Medical FCF Margin % Related Terms

Encore Medical FCF Margin % Historical Data

* Premium members only.

The historical data trend for Encore Medical's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Encore Medical FCF Margin % Chart

Encore Medical Annual Data
Trend Dec23 Dec24 Dec25
FCF Margin %
-116.60 -21.64 -25.87

Encore Medical Quarterly Data
Dec23 Sep24 Dec24 Jun25 Sep25 Dec25
FCF Margin % Get a 7-Day Free Trial -33.06 -13.20 0.00 -37.14 -19.38

EMI vs : FCF Margin % Comparison

For the Medical Instruments & Supplies subindustry, Encore Medical's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Encore Medical FCF Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Encore Medical's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Encore Medical's FCF Margin % falls into.


Encore Medical FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Encore Medical's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-0.669/2.586
=-25.87 %

Encore Medical's FCF Margin for the quarter that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-0.251/1.295
=-19.38 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -19.38% mean?
Encore Medical (EMI) has a FCF Margin % of -19.38% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Encore Medical and its competitors.
Is Encore Medical's FCF Margin % too high?
Encore Medical's current FCF Margin % is -19.38%.
How does Encore Medical's FCF Margin % compare to ?
Encore Medical's FCF Margin % of -19.38% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Encore Medical and its competitors. Encore Medical's current FCF Margin % is -19.38%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Encore Medical stock overvalued right now?
Encore Medical (EMI) has a current FCF Margin % of -19.38%. The current FCF Margin % is -19.38%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Encore Medical (EMI), the current FCF Margin % is -19.38% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Encore Medical Business Description

Comparable Companies
Address 2975 Lone Oak Drive, Suite 140, Eagan, MN, USA, 55121
Encore Medical Inc develops, manufactures, and markets septal occlusion devices for the repair of certain cardiac defects. Its products have been implanted in approximately 35,000 patients outside the United States. Its closure device is designed to correct a cardiac defect, generally diagnosed in adulthood, known as a patent foramen ovale (PFO). The company also currently market and sell septal occlusion devices for the transcatheter closure of atrial septal defects (ASD).